NASDAQ · Healthcare · Biotechnology
Tempest Therapeutics, Inc.
TPST
Tempest Therapeutics Inc. CEO Matthew Angel · Market cap $8.6M.
$1.94
-0.05 · -2.51%
52w hi $12.2352w lo $1.50
Off 52w high 85.4%
75
STRONG
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
1 strong · 0 notable
Analyst consensus
Strong Buy
—
Section 01
Recent Form 4 filings
1 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Mar 24 | Matthew Angel | CEO and President | Buy | 231,482 | $2.16 | +$500K | 75 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay